Ami Knoefler
Contatto Relazioni con gli Investitori presso ADAGENE INC.
Profilo
Ami Celeste Knoefler is the founder of Spark BioComm LLC.
She is currently the VP-Investor Relations & Communications at Adagene, Inc. Her former positions include Executive Director-IR & Corporate Communications at Jazz Pharmaceuticals, Inc., Director-Investor Relations at Abbott Biotherapeutics Corp., Director-Investor Relations at PDL BioPharma, Inc., Senior Director at Ascendis Pharma A, and Executive Director-Investor Relations at Jazz Pharmaceuticals Plc.
She received her undergraduate degree from Boston University in 1992.
Posizioni attive di Ami Knoefler
Società | Posizione | Inizio |
---|---|---|
ADAGENE INC. | Contatto Relazioni con gli Investitori | 01/07/2021 |
Spark BioComm LLC | Fondatore | - |
Precedenti posizioni note di Ami Knoefler
Società | Posizione | Fine |
---|---|---|
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01/05/2009 |
PDL BIOPHARMA, INC. | Public Communications Contact | 01/01/2008 |
ASCENDIS PHARMA A/S | Direttore/Membro del Consiglio | 01/08/2021 |
JAZZ PHARMACEUTICALS PLC | Public Communications Contact | - |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Contatto Relazioni con gli Investitori | - |
Formazione di Ami Knoefler
Boston University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
ASCENDIS PHARMA A/S | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
ADAGENE INC. | Health Technology |
Aziende private | 4 |
---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Spark BioComm LLC |
- Borsa valori
- Insiders
- Ami Knoefler